COURTESY RHODE ISLAND HOSPITAL 1. Lifespan announces ‘breakthrough’ in brain cancer research POSTED ONLINE: JAN. 6. Lifespan Cancer Institute researchers said the phase 3 trial of the DCVax-L vaccine showed improved survival rates in patients with newly diagnosed and returning glioblastoma, the most common and most lethal form of brain cancer. bit.ly/3jsschH 2.…
You must be a paid subscriber to read this content.
To keep reading and receive unlimited access subscribe today for only $1.
Subscribe Now
Already a Subscriber?
Login now
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
